The use of base editing to generate universal off-the-shelf CAR T cells induced durable remissions -- up to 36 months in one ...

UW researchers found potential new treatments for a rare pediatric brain cancer each year that has a median survival time of ...

US scientists discover a new gene therapy technique that is able to modify prostate cancer cells so that a patient's body attacks and kills them.

A patient death in a CRISPR trial halts gene editing studies, raising critical safety questions. What this means for the ...

Cell and gene therapies use the body's building blocks - cells and genetic material - to boost the immune system or correct ...

Immune checkpoint inhibitors (ICIs) have revolutionized cancer therapy by harnessing the body's immune system to target ...

Expected rapid advances in CAR T and other cellular therapies may expand treatment options not only in cancer but also in ...

According to Dr. Jennifer Levin Carter, MD, founder and CEO of Medzown, the concept of personalized medicine shifted from a ...

Scientists at St. Jude Children's Research Hospital have revealed previously unappreciated roles for the retrotransposon LINE ...

Glioblastoma remains one of the most challenging solid tumors to treat due to its highly immunosuppressive tumor microenvironment.

Cell-based immunotherapies have transformed cancer treatment, yet their widespread use remains constrained by safety risks, ...

Genetic and metabolic differences may increase aggressive early breast cancer risk in Latin American women with obesity, ...